谷歌浏览器插件
订阅小程序
在清言上使用

LBA20 First-line Carboplatin-Cyclophosphamide (CC) Versus Paclitaxel (P) with or Without Atezolizumab (atezo) for Metastatic Triple Negative Breast Cancer (mtnbc): Results from a Multicenter, Randomized Phase IIb Trial: the Triple-B Study (BOOG 2013-01)

Annals of Oncology(2024)

引用 0|浏览5
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要